Jaguar Health, Inc. (NASDAQ:JAGX – Get Free Report) was the target of a significant decline in short interest in March. As of March 15th, there was short interest totalling 35,700 shares, a decline of 96.3% from the February 28th total of 953,100 shares. Based on an average daily volume of 22,800 shares, the short-interest ratio is currently 1.6 days. Approximately 0.3% of the shares of the stock are sold short.
Jaguar Health Stock Down 5.2 %
Shares of Jaguar Health stock traded down $0.28 during midday trading on Wednesday, hitting $5.13. 52,850 shares of the company traded hands, compared to its average volume of 27,889. The company has a current ratio of 1.84, a quick ratio of 1.36 and a debt-to-equity ratio of 1.65. The firm’s fifty day moving average price is $17.15 and its 200-day moving average price is $23.55. Jaguar Health has a 12 month low of $4.90 and a 12 month high of $540.00.
Institutional Trading of Jaguar Health
An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC acquired a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned about 0.22% of Jaguar Health at the end of the most recent reporting period. Institutional investors and hedge funds own 12.04% of the company’s stock.
Analyst Ratings Changes
View Our Latest Research Report on JAGX
About Jaguar Health
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.
Further Reading
- Five stocks we like better than Jaguar Health
- Investing in Commodities: What Are They? How to Invest in Them
- Energy Transfer: Powering Data With Dividends and Diversification
- What is diluted earnings per share (Diluted EPS)?
- Qualcomm Stock Is Coiling for a Breakout
- Find and Profitably Trade Stocks at 52-Week Lows
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.
